Applied Therapeutics' Govorestat Faces Unclear Regulatory Path After FDA Rejection, RBC Says

In This Article:

Applied Therapeutics' (APLT) lead drug govorestat faces "significant uncertainties" around a regulat

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.